Gil Melmed
Director, Inflammatory Bowel Disease Clinical Research · Cedars-Sinai Medical Center
Credentials: · · ·
History
PresentInflammatory Bowel Disease Clinical Research · Cedars-Sinai Medical Center
- Present
- 2003–2006
Gastroenterology
1996–2000
Research
Genome-wide association identifies multiple ulcerative colitis susceptibility loci
Nature Genetics · 2010 · 544 citations
ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease
Review · The American Journal of Gastroenterology · 2017 · 399 citations
The Journal of Immunology · 2003 · First of 10 authors · 329 citations
61 papers
55 papers
- ST
52 papers
48 papers
- EV
41 papers
- MD
31 papers
- AI
28 papers
20 papers
Grants
- 2021–2026
Targeting the Mycobiome in Genetically Defined Patients with Crohns Disease
National Institute of Diabetes and Digestive and Kidney Diseases · R01
PI · $2.5M · Cedars-Sinai Medical Center
Clinical trials
- 2022–2025
Pilot Study of Posaconazole in Crohn's Disease
Principal investigator · Terminated · Phase 4
Cedars-Sinai Medical Center
- 2019–2022
Dynamic Web-Based Interventions to Improve Update of Preventive Health Recommendations in IBD
Principal investigator · Completed
Cedars-Sinai Medical Center
- 2019–2022
Reactive vs. Proactive Pain Control in IBD
Principal investigator · Terminated
Cedars-Sinai Medical Center
- 2018
Maintenance Dosing of Vitamin D in Crohn's Disease
Principal investigator · Terminated · Early phase 1
Cedars-Sinai Medical Center